EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Clinical and cellular phenotypes resulting from a founder mutation in IL10RB

Zhiming Mao iD, Michael J Betti, Miguel A Cedeno, Luis A Pedroza, Shamel Basaria, Qi Liu, Joseph M Choi, Janet G Markle iD

Clinical and Experimental Immunology · 2024

DOI: 10.1093/cei/uxad085 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical and Experimental Immunology, 2024. Verfasst von Zhiming Mao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Founder Effect, Inflammatory Bowel Diseases, Phenotype. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, Johns Hopkins Digestive Diseases Basic and Translational Research Core Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inborn errors of immunity are a group of rare genetically determined diseases that impair immune system development or function. Many of these diseases include immune dysregulation, autoimmunity, or autoinflammation as prominent clinical features. In some children diagnosed with very early onset inflammatory bowel disease (VEOIBD), monogenic inborn errors of immune dysregulation underlie disease. We report a case of VEOIBD caused by a novel homozygous loss of function mutation in IL10RB. We use cytometry by time-of-flight with a broad panel of antibodies to interrogate the immunophenotype of this patient and detect reduced frequencies of CD4 and CD8 T cells with additional defects in some populations of T helper cells, innate-like T cells, and memory B cells. Finally, we identify the patient’s mutation as a founder allele in an isolated indigenous population and estimate the age of this variant by studying the shared ancestral haplotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Founder EffectInflammatory Bowel DiseasesPhenotypeFemaleHumansInfantMaleB-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHaplotypesImmunophenotypingInterleukin-10 Receptor beta SubunitLoss of Function MutationMutation

Stichwörter der Autor:innen

IL-10founder mutationinflammatory bowel disease

Substanzen

Interleukin-10 Receptor beta SubunitIL10RB protein, human

Autor:innen und Institutionen

  • Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Department of Pediatrics, Hospital de ninos Roberto Gilbert Elizalde, Guayaquil, Ecuador.
  • Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
  • Division of Molecular Pathogenesis, Department of Pathology Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

ORCID-Profile: Zhiming Mao, Janet G Markle

Förderung

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • Johns Hopkins Digestive Diseases Basic and Translational Research Core Center
  • Vanderbilt University Medical Center’s Digestive Disease Research Center

Zitieren

APA

Mao, Z., Betti, M. J., Cedeno, M. A., Pedroza, L. A., Basaria, S., Liu, Q., Choi, J. M., & Markle, J. G. (2024). Clinical and cellular phenotypes resulting from a founder mutation in IL10RB. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxad085

Vancouver

Mao Z, Betti MJ, Cedeno MA, Pedroza LA, Basaria S, Liu Q, et al. Clinical and cellular phenotypes resulting from a founder mutation in IL10RB. Clinical and Experimental Immunology. 2024. doi:10.1093/cei/uxad085

BibTeX
@article{Mao2024,
  author = {Mao, Zhiming and Betti, Michael J and Cedeno, Miguel A and Pedroza, Luis A and Basaria, Shamel and Liu, Qi and Choi, Joseph M and Markle, Janet G},
  title = {Clinical and cellular phenotypes resulting from a founder mutation in IL10RB},
  journal = {Clinical and Experimental Immunology},
  year = {2024},
  doi = {10.1093/cei/uxad085}
}
Kostenlos starten →